Bioavailability enhancement technologies for poorly soluble molecules
Dear Kenneth,
Resolving complex issues with solubility and bioavailability is key to advancing molecules through development. Learn more now about how Patheon’s Quadrant 2® platform is using in silico predictive AI technology to reduce the risk of costly delays.
An accurate view of future challenges
Explore the capabilities of Quadrant 2 in this interactive infographic from Pharma Ignite and Thermo Fisher Scientific.
View the infographic to gain insights on how Quadrant 2 helps you:
- Analyze your API’s chemical structure and known physicochemical properties
- Identify potential solubility enhancement technologies such as spray drying, HME, lipid formulations, and solid-state chemistry
- Compare the solubility enhancement technologies most likely to succeed for your molecule
- Align solubility strategies with your business and clinical goals
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting Pharma Ignite or a third party to contact you regarding the content (by phone or email).
© 2026 Marketing Masters Hub. All rights reserved.